Certain Financial Statement Caption Information (Tables)

3 Months Ended

Mar. 31, 2023

Certain Financial Statement Caption Information [Abstract]

Schedule of Company's Short-Term Investments

The following table summarizes the Company’s short-term investments (in thousands):

	Maturity	Amortized		Unrealized		Unrealized			Estimated
	(in years)	Cost		Gains		Losses			Fair Value
March 31, 2023
U.S. treasury securities	1 or less	$	37,483	$	10	$	(4	)	$	37,489
Total		$	37,483	$	10	$	(4	)	$	37,489
December 31, 2022
U.S. treasury securities	1 or less	$	12,006		-		(90	)	$	11,916
Total		$	12,006	$	-	$	(90	)	$	11,916

Schedule of Accrued Expenses

Accrued expenses consisted of the following (in thousands):

	March 31,		December 31,
	2023		2022
Clinical development	$	3,313	$	3,253
Accrued payroll and other employee benefits		976		2,975
Other accruals		732		472
Non-clinical research		356		465
Accrued interest		66		74
Total accrued expenses	$	5,443	$	7,239